Apellis Pharmaceuticals, Inc. (APLS)
18.85
-0.02
(-0.11%)
USD |
NASDAQ |
Mar 17, 14:24
Apellis Pharmaceuticals Profit Margin (Quarterly) : -29.49% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 6.09% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Amicus Therapeutics, Inc. | 0.91% |
| Ionis Pharmaceuticals, Inc. | -112.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.48% |
| Return on Assets | 2.41% |
| Return on Invested Capital | 3.04% |
| Gross Profit Margin (Quarterly) | 85.13% |
| Operating Margin (Quarterly) | -25.58% |
| Return on Net Operating Assets | 5.03% |